Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
about
Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutationDifferential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in Friedreich ataxia fibroblastsAntioxidant-mediated effects in a gerbil model of iron overloadStem cells from wildtype and Friedreich's ataxia mice present similar neuroprotective properties in dorsal root ganglia cells.An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse modelsMesenchymal stem cells improve motor functions and decrease neurodegeneration in ataxic mice.Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy.Redox processes in neurodegenerative disease involving reactive oxygen speciesPredictors of progression in patients with Friedreich ataxiaCellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.Coenzyme Q10 effects in neurodegenerative disease.Drugs interfering with mitochondrial disorders.Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases.Strategies for oral delivery and mitochondrial targeting of CoQ10.Therapeutic approaches for the treatment of Friedreich's ataxia.Pharmacological therapeutics in Friedreich ataxia: the present state.A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins.Genetic evidence for the requirement of the endocytic pathway in the uptake of coenzyme Q6 in Saccharomyces cerevisiaeAnalysis of the visual system in Friedreich ataxia.Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia.Cytokine toxicity to oligodendrocyte precursors is mediated by iron.Ubiquinone and carotene production in the Mucorales Blakeslea and Phycomyces.Rehabilitation management of Friedreich ataxia: lower extremity force-control variability and gait performance.
P2860
Q26853254-D4A6DCC7-6EFD-4124-BA58-B674B3490CC9Q28307360-77B378A2-59B2-41B2-9CE1-D0DEB0E95A03Q33936940-0DCD6AC6-1792-4BEB-A44A-356336AC1DAAQ33944090-F9E71A9D-A963-43BF-ABCB-1D6D615D210CQ34720833-3F26444B-B020-4071-A47D-73BD119EAADBQ35184184-743A527C-FF81-4A51-9397-D7DCBA01B3C4Q35591375-8223BD0C-8066-4EF5-84D4-C1BD71BA0F17Q36444526-5A46ACBA-3438-4558-BCE0-FA1431445074Q36460613-401D6919-1483-47B3-B275-46154B583BA1Q36964121-2D0F3107-1218-4AD2-87CD-876128B72033Q37217435-0EE34BF5-2B8B-4234-8B01-F246460E2B42Q37448888-B2076E5D-9395-4329-8744-B2484E0DD2DDQ37617357-03D618CF-4214-4A16-B1E3-51494BA3DB21Q37963369-E99E04C9-84AB-4A61-A0EF-9CBC3EE27198Q38301993-B8CF3691-5356-4459-8C12-99539FE01167Q39158402-16B76A7B-2DF8-4421-B897-F41EED19E0ADQ39445743-4BFB5B9D-EE21-49DC-9DC2-F520F727ED30Q39793086-29E32C96-E049-4996-B17F-34E07DB268EAQ41916653-318426E9-C24E-4218-A0A0-97CE36ABE3FCQ45809518-74638E52-A46E-4D62-A80E-A0A6262428DCQ45863203-245CBABA-84C7-482E-8D0A-302AFEECB591Q48843970-AF0A17D0-B925-45D3-A44D-5744ACCA668BQ50962191-3FC94335-8B01-4455-9142-94263BD772EBQ51653593-FC6DD487-5E81-4491-95BF-88E713914354
P2860
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@ast
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@en
type
label
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@ast
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@en
prefLabel
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@ast
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@en
P2860
P356
P1433
P1476
Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
@en
P2093
Schapira AH
P2860
P304
P356
10.1002/BIOF.5520180219
P577
2003-01-01T00:00:00Z